Heron Therapeuti
Statements
Cash Flow
Heron Therapeuti (HRTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -2.2 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36 | -39 | -51 | -32 | -41 | -47 | -62 | -61 | -36 | -33 | -49 | -23 | -25 | -27 | -33 | -57 | -42 | -53 | -42 | -63 | -53 | -45 | -44 | -28 | -37 | -38 | -25 | -27 | -9.2 | 2.5 | -9.5 | -4.6 | 3.4 | -12 | -8.9 | -11 | 1.3 | -9.2 | -1.5 | -2.2 | -12 | |
| 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.8 | 0.9 | 1.1 | 1.1 | 1.1 | 1.2 | 1.0 | 0.8 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.6 | 1.0 | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 2.1 | |
| 7.5 | 7.3 | 8.0 | 8.2 | 7.5 | 6.9 | 7.7 | 7.8 | 8.1 | 9.8 | 18 | 13 | 9.7 | 11 | 12 | 11 | 11 | 16 | 11 | 11 | 11 | 13 | 11 | 10 | 11 | 11 | 7.9 | 14 | 6.7 | 4.3 | 3.4 | 4.6 | 2.7 | 2.3 | 2.5 | 2.8 | 2.9 | 2.2 | 3.0 | 3.2 | 11 | |
| 7.5 | 7.3 | 8.0 | 8.2 | 7.5 | 6.9 | 7.7 | 7.8 | 8.1 | 9.9 | 18 | 13 | 9.7 | 11 | 12 | 11 | 11 | 17 | 12 | 11 | 11 | 14 | 11 | 10 | 11 | 10 | 8.1 | 14 | 6.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 4.4 | 1.6 | -8.8 | 2.2 | -6.6 | 7.8 | -18 | -30 | -5.1 | 7.0 | -3.3 | 15 | -1.6 | 18 | -3.0 | -21 | 10 | 3.2 | -3.3 | -24 | -7.7 | -3.3 | 3.6 | 11 | 0.4 | -25 | -1.4 | 2.5 | 8.5 | 8.4 | -10 | -3.4 | 4.3 | -18 | -14 | -12 | 3.6 | -9.1 | 3.0 | -0.4 | -2.9 | |
| 0.5 | 0.7 | 0.9 | 0.5 | 0.0 | 1.1 | 0.9 | 1.3 | 3.5 | 3.5 | 2.1 | 2.2 | 1.0 | 3.9 | 2.9 | 0.7 | 0.6 | 2.5 | 0.8 | 0.3 | 1.5 | 0.4 | 1.0 | 0.3 | 0.0 | 0.4 | 0.2 | 0.3 | 0.8 | 0.3 | 0.0 | 0.6 | 0.4 | 0.6 | 0.1 | 0.2 | 0.0 | 0.0 | 0.4 | 0.1 | 0.5 | |
| -31 | 4.8 | -45 | 2.4 | 71 | -20 | -40 | -97 | -149 | 8.3 | 34 | 42 | 29 | -126 | 64 | 32 | 56 | 57 | -4.3 | 40 | 22 | -24 | 11 | 20 | -36 | 2.0 | 37 | 13 | -23 | -8.8 | 1.3 | 2.0 | 4.0 | 11 | 2.3 | 7.3 | 12 | -5.5 | -0.9 | -3.3 | 2.2 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 338 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.0 | 1.5 | 166 | 1.4 | 5.2 | 147 | -0.2 | 370 | 5.1 | 0.2 | 6.5 | 11 | 3.9 | 165 | 0.5 | 2.3 | 0.5 | 5.7 | 0.9 | 5.7 | -0.1 | 0.5 | – | 0.8 | 75 | – | – | 0.7 | – | – | – | – | – | – | – | – | – | – | -0.1 | -0.1 | – | |
| 50 | 50 | -25 | -25 | – | -25 | -25 | -25 | -25 | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 149 | 149 | 0.0 | – | – | – | – | 24 | 24 | 24 | 24 | – | – | – | – | 0.0 | – | – | – | -4.8 | – | – | – | |
| 51 | 1.5 | 166 | -24 | 5.2 | 147 | 4.0 | 370 | -20 | 3.1 | 6.5 | 11 | 3.9 | 165 | 0.5 | 2.3 | 0.5 | 5.8 | 0.9 | 155 | -0.1 | 0.5 | -0.6 | 0.3 | 75 | 0.4 | -0.2 | 0.3 | 54 | 0.2 | 0.0 | 0.5 | 0.0 | 0.4 | 0.1 | 0.8 | 13 | 0.2 | -0.1 | 0.1 | 14 | |
| -16 | -32 | 70 | 30 | 66 | 145 | -98 | 212 | -205 | -22 | -8.4 | 30 | 7.1 | 12 | 31 | -23 | 14 | 10.0 | -45 | 131 | -32 | -69 | -34 | -8.3 | 1.8 | -35 | 12 | -14 | 21 | -6.2 | -8.2 | -2.1 | 7.4 | 0.1 | -6.5 | -2.8 | 27 | -14 | -2.5 | -5.4 | 4.2 | |
| -37 | -39 | -52 | -33 | -41 | -48 | -63 | -62 | -39 | -37 | -51 | -25 | -24 | -31 | -36 | -58 | -43 | -55 | -43 | -63 | -55 | -46 | -45 | -29 | -37 | -38 | -25 | -27 | -10.0 | 2.2 | -9.5 | -5.2 | 2.9 | -12 | -9.0 | -11 | 1.3 | -9.2 | -1.9 | -2.4 | -12 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.